Publications Database

Abanilla P. K. et al. (2005)

The use of psychostimulants in pervasive developmental disorders.

Psychiatric Quarterly

76(3), pp. 271-281

Read Abstract (New Window)

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Adams J. B. et al. (2011)

Effect of a vitamin-mineral supplement on children and adults with autism.

BMC Pediatrics

11(1), pp. 111

Read Abstract (New Window) Read Full (New Window)

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Ali G. et al. (2016)

Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

November, 26(9), pp. 784-791.

Read Abstract (New Window)

Amalu W. C. (1998)

Autism, asthma, irritable bowel syndrome, strabismus, and illness susceptibility: A case study in chiropractic management.

Today's Chiropractic

27(5), pp. 32-47

Read Full (New Window)

Aman M. G. et al. (2014)

A review of atomoxetine effects in young people with developmental disabilities.

Research in Developmental Disabilities

June, 35(6), pp. 1412-1424.

Read Full (New Window)

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Aman M. G. (1982)

Stimulant drug effects in developmental disorders and hyperactivity: toward a resolution of disparate findings.

Journal of Autism and Developmental Disorders

12(4), pp. 385-398

Read Abstract (New Window)

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

Amminger G. et al. (2007)

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

Biological Psychiatry

61(4), 551-553

Read Abstract (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Arnold L. E. et al. (2006)

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

Journal of the American Academy of Child and Adolescent Psychiatry

45(10), pp. 1196-1205

Read Abstract (New Window)

Arnold L. E. et al. (2003)

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

Journal of the American Academy of Child and Adolescent Psychiatry

42(12), pp. 1443-1450

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

22(3), pp. 198-205.

Read Abstract (New Window)

Awad G. A. (1996)

The use of selective serotonin reuptake inhibitors in young children with pervasive developmental disorders: some clinical observations.

Canadian Journal of Psychiatry

August, 41(6), pp. 361-366

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

An update on medication management of behavioral disorders in autism.

Current Psychiatry Reports

16(3), pp. 437

Read Abstract (New Window)

Barnard A. L. et al. (2002)

A systematic review of the use of atypical antipsychotics in autism.

Journal of Psychopharmacology

16(1), pp. 93-101

Read Abstract (New Window)

Bent S. et al. (2011)

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder.

Journal of Autism and Developmental Disorders

41(5), pp. 545-554.

Read Abstract (New Window) Read Full (New Window)

Bent S. et al. (2014)

Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.

Journal of the American Academy of Child and Adolescent Psychiatry

June, 53(6), pp. 658-666.

Read Abstract (New Window)